B-FAHF-2 plus oral immunotherapy (OIT) is safer and more effective than OIT alone in a murine model of concurrent peanut/tree nut allergy.
B-FAHF-2 plus oral immunotherapy (OIT) is safer and more effective than OIT alone in a murine model of concurrent peanut/tree nut allergy.
复制标题
DOI:
10.1111/cea.12936
复制
发表时间:
2017-08
期刊:
影响因子:
--
通讯作者:
Li XM
中科院分区:
文献类型:
--
作者:
Srivastava KD;Song Y;Yang N;Liu C;Goldberg IE;Nowak-Węgrzyn A;Sampson HA;Li XM
Concurrent sensitization to peanut (PN) and tree nuts (TN), the most dangerous food allergies, is common. Current oral immunotherapy (OIT) is not fully satisfactory. To determine if the herbal formula B-FAHF-2 (BF2) ameliorates PN/TN OIT adverse reactions and enhances persistence of a tolerant state. Concurrently sensitized peanut, walnut (WN) and cashew (CSH) allergic mice received 1 day PN/WN/CSH rush OIT plus 3 weeks of maintenance dosing, with or without 3-weeks prior and 3-weeks BF2 co-treatment. Anaphylactic symptom scores, core body temperatures, plasma histamine levels, basophil numbers, antigen-specific IgE, cytokine levels, and IL-4, INF-γ and Foxp3 gene promoter DNA methylation status, and their correlation with final challenge symptom scores were determined. BF2+OIT treated mice experienced significantly fewer and less severe adverse reactions than OIT only treated mice (p<0.01) during the one-day rush OIT buildup dose phase. Both OIT only and BF2+OIT mice showed significant desensitization (p<0.01 and 0.001 respectively) at one-week post therapy challenge; being greater in BF2+OIT mice. All sham treated and 91% of OIT treated mice experienced anaphylaxis whereas only 21% of BF2+OIT treated mice exhibited reactions during 5–6 weeks of dose escalation single PN and TN challenges. Greater and more persistent protection in BF2+OIT mice was associated with significantly lower plasma histamine and IgE levels, increased IFN- γ/IL-4 and IL-10/IL-4 ratios, DNA re-methylation at the IL-4 promoter and de-methylation at IFN-γ and Foxp3 promoters. Final challenge symptom scores were inversely correlated with IL-4 DNA methylation levels (p<0.0002), and positively correlated with IFN-γ and Foxp3 gene promoter methylation levels (p<0.0011) (p<0.0165). Combined BF2/OIT therapy was safer and produced longer post treatment protection, and more tolerance-prone immunological and epigenetic modifications than OIT alone. BF2/OIT may provide an additional OIT option for patients with concurrent peanut/ tree nut and other food allergies.
登录
查看更多内容
DOI:
10.1016/j.jaci.2010.10.007
发表时间:
2010-12
期刊:
The Journal of allergy and clinical immunology
影响因子:
--
作者:
NIAID-Sponsored Expert Panel;Boyce JA;Assa'ad A;Burks AW;Jones SM;Sampson HA;Wood RA;Plaut M;Cooper SF;Fenton MJ;Arshad SH;Bahna SL;Beck LA;Byrd-Bredbenner C;Camargo CA Jr;Eichenfield L;Furuta GT;Hanifin JM;Jones C;Kraft M;Levy BD;Lieberman P;Luccioli S;McCall KM;Schneider LC;Simon RA;Simons FE;Teach SJ;Yawn BP;Schwaninger JM
通讯作者:
Schwaninger JM
影响因子:
2.8
作者:
Beigelman, Avraham;Strunk, Robert C.;Bacharier, Leonard B.
通讯作者:
Bacharier, Leonard B.
影响因子:
5.6
作者:
Liu C;Yang N;Song Y;Wang L;Zi J;Zhang S;Dunkin D;Busse P;Weir D;Tversky J;Miller RL;Goldfarb J;Zhan J;Li XM
通讯作者:
Li XM
影响因子:
14.2
作者:
Gorelik, Mark;Narisety, Satya D.;Frischmeyer-Guerrerio, Pamela A.
通讯作者:
Frischmeyer-Guerrerio, Pamela A.
影响因子:
14.2
作者:
Leonard, Stephanie A.;Martos, Gustavo;Wang, Wei;Nowak-Wegrzyn, Anna;Berin, M. Cecilia
通讯作者:
Berin, M. Cecilia